-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
-
Summary
-
Teva Pharmaceutical Industries Ltd quarterly Deferred Income Tax Assets, Net history and growth rate from Q4 2019 to Q4 2024.
- Teva Pharmaceutical Industries Ltd Deferred Income Tax Assets, Net for the quarter ending December 31, 2024 was $1.8B, a 0.72% decline year-over-year.
Deferred Income Tax Assets, Net, Quarterly (USD)
Deferred Income Tax Assets, Net, YoY Quarterly Growth (%)